Friedman Charlene A 4
4 · MAP Pharmaceuticals, Inc. · Filed Jan 29, 2013
Insider Transaction Report
Form 4
Friedman Charlene A
VP President, Gen Counsel &Sec
Transactions
- Exercise/Conversion
Common Stock
2013-01-26+2,250→ 5,100 total - Tax Payment
Common Stock
2013-01-25$24.75/sh−1,207$29,873→ 2,850 total - Exercise/Conversion
Common Stock
2013-01-25+2,750→ 4,057 total - Tax Payment
Common Stock
2013-01-26$24.75/sh−871$21,557→ 4,229 total
Footnotes (3)
- [F1]Each RSU represents a contingent right to receive one share of MAP common stock.
- [F2]25% of the total number of RSU granted on January 25, 2012 vested on January 25, 2013.
- [F3]25% of the total number of RSU granted on January 26, 2011 vested on January 26, 2013.